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Introduction
Premature mortality post-fracture is well established for hip and vertebral fractures (1-3).
There is increasing evidence that a range of other, non-hip non-vertebral (NHNV), osteoporotic fractures are also associated with increased mortality (4) (5) (6) . However, published data are inconsistent, particularly for distal forearm fractures (7, 8) , or lacking for many other fractures.
This potential association is important because NHNV fractures account for over 50% of fractures. Compared to hip and vertebral fractures, they receive less attention (9) , possibly due to clinicians' perception they are not associated with adverse consequences, or to difficulties accessing accurate data as they often do not require hospital admission. However, there is increasing evidence that NHNV fractures contribute significantly to the burden of subsequent fractures (10, 11) and increased premature mortality (5, 12, 13 ).
Previous studies of NHNV fractures and mortality have a number of limitations (8, 12, (14) (15) (16) (17) . In particular, apart from sites such as the humerus (17, 18) and distal forearm (8, 19) , NHNV fractures are commonly grouped (20, 21) , due to limited fracture numbers for specific sites. In addition, data on co-morbidities, and other potential confounders for mortality, are often lacking.
To overcome some of these limitations, we used a large population cohort with baseline comorbidity data and linkage capabilities to examine the relationship of hip, vertebral and multiple NHNV fracture sites with mortality. The study aims were to examine: (1) the relationship between mortality and individual NHNV fracture sites, and (2) the independent contribution of fracture and co-morbidity to mortality.
Subjects and Methods
The Sax Institute's 45 and Up study is a prospective cohort study of over 260,000 residents of New South Wales (NSW), Australia. NSW's population accounts for one-third of Australia's population. The study, described previously (22) , included subjects 45 and older who were invited to participate via random sampling of the Department of Human Services (formerly Medicare Australia) enrolment database, which provides near complete coverage of the Australian population. To allow for deaths and loss to follow-up, the study over-sampled by a factor of two, individuals 80+ years and individuals in rural areas. Recruitment occurred between 2005 and 2009. The response rate was 18% and the study cohort was healthier and better educated than the general NSW population (23) . Participants completed a baseline questionnaire and consented to data linkage to a number of administrative health datasets. For this analysis participants were followed until 31 December 2013. To ensure a minimum 12-month follow-up post-fracture, participants who fractured in the last follow-up year were excluded.
Questionnaire Variables
Demographic data (age, date of recruitment, sex), lifestyle (smoking status, body mass index (BMI)) and co-morbidities were obtained from the baseline questionnaire. Co-morbidities included cardiovascular disease, cerebrovascular disease, thrombotic disorders, diabetes, melanoma, breast cancer, prostate cancer, and all other cancers including non-melanoma skin cancer and prior fracture within the last five years. For co-morbidities, participants were asked whether "a doctor ever told you that you have" the condition (Yes/No). BMI was derived from self-reported height and weight. Smoking status was classified as never, previous or current. Alcohol intake was classified in three categories as none; within the Australian National Health and Medical Research Council guideline recommendations (≤ 2 standard drinks/day for women and ≤ 4 standard drinks/day for men, with 2 alcohol free days per week for both sexes); and exceeding guidelines. 
Linked databases

Fracture identification
Fractures were identified through a combination of SNOMED-CT and ICD-10 diagnosis codes from the APDC and EDDC as outlined above, and also using the Australian Classification of Health Interventions (ACHI) (26) procedure codes to capture fractures presenting as a day procedure. All SNOMED-CT and ICD-10 diagnosis codes suggesting fractures resulting from high trauma and pathological fractures were excluded. In participants with 2 or more fractures during one admission, only the more axial fracture, deemed the most severe, was counted.
Outcome measures
The primary outcome was all-cause mortality following each fracture type adjusted for age, lifestyle factors and co-morbidities.
Statistical analysis
Participants who died were compared to those alive at the study end for women and men separately. Student's t-test was used to compare baseline characteristics for continuous variables and Pearson's 2 test for categorical variables. Fracture incidence and mortality were calculated as fractures and deaths per 1000 person-years of follow-up. Fracture incidence was calculated for age groups: 45-59, 60-74 and 75+. Individual covariates were examined for their relationship with mortality using Cox's proportional hazard models.
Significance and 95% confidence intervals were calculated assuming a Poisson distribution.
Mortality rates were age standardised to the 2001 Australian population as recommended by the Australian Bureau of Statistics. As overall mortality rate of the study cohort was lower than the general Australian population, particularly in the 85+ age cohort, standardised mortality ratios, comparing the cohort and NSW population, are not presented. Mortality differences were compared within the cohort between fracture and non-fracture participants in several analyses.
Cox's proportional hazards regression was used to examine the association between fracture type and mortality with adjustment for covariates. Fracture was included as a time-dependent variable. Survival time was measured from recruitment until death or censor date. The proportional hazards assumption was checked for each variable by examining the residual plots. Thus age-and sex-specific adjusted hazard ratios (HR) were derived. Body mass index were missing in 11000 women (8.5%) and 7650 men (6.3%). These participants were excluded from the final modelling. Sensitivity analysis with imputation using the median BMI did not change the analysis meaningfully.
To examine the effect of co-morbidities on survival for different fracture types, estimated survival function curves with covariates were plotted using the baseline function in SAS. We chose humeral fracture as representative of a NHNV fracture to compare with the known increased mortality of hip fracture. Curves were plotted for women and men aged 60 or 80 for none, one or two co-morbidities, in addition to fracture.
To calculate population attributable fraction, the heuristic approach was taken (17) using combinations of six key risks (fracture during the study; baseline cardiovascular disease, diabetes, stroke, cancer and thrombosis) resulting in 64 possible exposure levels. Participants who did not fracture, with no co-morbidities were the reference.
Analyses were performed using SAS 9.3 (SAS Institute, Inc. Cary, NC, USA).
Results
The study included data from 141,342 women and 122,877 men. Mean age (SD) was 61. (Table 1) .
Fracture incidence
During follow-up, women had 7,571 and men had 4,571 incident fractures, yielding fracture incidence rates of 9.71/1000 person-years (95% CI: 9.50-9.94) in women and 7.09/1000
person-years (95% CI: 6.89-7.30) in men. Pattern of fractures were similar between women and men ( Figure 1 ). NHNV accounted for over 70% of fractures in both women and men.
There was an exponential increase in hip fractures, particularly after 75 years, and increased incidence of vertebral, pelvic, rib and humeral fractures with increasing age. Distal forearm fractures increased with age in women but not in men. By contrast, NHNV fracture at other sites, e.g. elbow and proximal tibia/fibula, remained relatively stable with increasing age.
Women had more distal site (distal forearm and ankle) fractures than men (P<0.001).
Mortality
Mortality rates were lower in the cohort than in the general Australian population (age Specific co-morbidities associated with increased mortality included cardiovascular disease, diabetes, stroke, and thrombotic disorders with age-adjusted mortality HRs ranging from 1.2- Table S1 ). Cancers other than breast or prostate were associated with the highest mortality risk (HR: 2.1-2.2). Low and high BMI and prior and current smoking were associated with increased mortality (HR: 1.4-2.7). Skin cancers other than melanoma were associated with a lower age-adjusted mortality risk. Alcohol intake in the cohort was low with 88% of women and 87% of men drinking within the recommended Australian alcohol guidelines or not drinking at all (non-drinkers: 41% and 23% in women and men, respectively). There was no clinically significant association between alcohol intake and mortality for either women or men.
(Supplementary
Fracture and mortality risk
Increased mortality was observed for many different fracture sites in both women and men.
This remained significant after multivariable adjustment (Figure 2 , Supplementary Table S2 ).
In general, mortality risk post fracture was greater in men than women (P<0.001 respectively). For these analyses, co-morbidities selected were those most common in the cohort, namely cardiovascular disease and diabetes. These survival curves demonstrate fracture as a risk factor for mortality, and the additional independent contribution of comorbidities. Indeed a woman with a humerus fracture and one co-morbidity had the same estimated 5-year survival as a woman with a hip fracture and no co-morbidities. A man with a humeral fracture and one co-morbidity had a somewhat better survival than a man with a hip fracture and no co-morbidities but having 2 co-morbidities together with a humeral fracture resulted in a greater 5 year mortality than a hip fracture alone.
Population attributable fraction
The proportion of deaths in the population that could be attributed to fracture in individuals without co-morbidity was 9.2% in women and 5.3% in men. In women, the PAF was less than cancer but of a similar magnitude to cardiovascular disease and diabetes. Fracture incidence was lower and cardiovascular disease higher in men than women; as a result the PAF of any fracture in men was less than cardiovascular disease but similar to diabetes and cancer. However, the contribution of fracture with or without any single co-morbidity resulted in a PAF for mortality that was similar to cancer in women and cardiovascular disease in men (Tables 2a & 2b) .
Discussion
In this large population-based cohort study of subjects aged 45 and older, a large range of NHNV fractures, in addition to hip and vertebral fractures, were associated with increased mortality risk, after adjusting for age, prior fracture, smoking, BMI, cancer and other major co-morbidities. Virtually all NHNV fractures, including ribs, pelvis, femur, elbow, proximal tibia/fibula, distal forearm in both sexes, as well as ankle in men, were associated with increased mortality post fracture with hazard ratios ranging from 1.3 to 3.4. Notably the mortality reported represents an early post fracture mortality with median time of 2.6 years from fracture to death or study end. Peripheral fractures of hands and feet were not associated with increased mortality. Moreover, this study demonstrated that co-morbidity contributed to mortality independently and additively from the fracture itself. The proportion of deaths that could be attributable to subjects with fracture alone or with fracture and one co-morbidity was of a similar magnitude to other major illnesses including cancer and heart disease, highlighting the magnitude of the problem.
We found that hip and vertebral fractures were associated with 3.0-fold and 2.7-fold increase in mortality, respectively, similar to previous reports (3). In relation to NHNV post-fracture mortality, humeral fractures have been the most frequently studied, with consistent findings of increased mortality (2, 15, 17, 18) . Our study supports these findings, demonstrating humeral fractures were associated with a two-fold increase in mortality in women (HR: 2.0) and men (HR: 1.95) after multivariable adjustment. Prior studies which have demonstrated increased mortality have not always discriminated by sex (2) and none has adjusted for comorbidities (2, 15, 17, 18) . Adjustment for co-morbidities in the current study had minimal effect on the fracture-mortality association itself but added an additional independent contribution to mortality.
The relationship between distal forearm fractures and mortality is controversial with conflicting data. Studies have variously reported increased (8, 27) , similar (2, 7, 20, 28) or decreased mortality (16, 19) . We found significant mortality increases of 30% and 50% (HR Few studies have examined mortality after rib fractures. Of these, only three examined rib fractures as a distinct group. The Study of Osteoporotic Fractures reported a three-fold increased mortality following rib fractures in women (29) . Of the remaining two studies, one found no difference in mortality risk but with only 16 and 11 rib fractures in men and women, respectively (25). In the other study (21) increased mortality risk post rib fractures was observed for women but not men. By contrast, in the current study, rib fractures were associated with an increased mortality risk of similar magnitude (two-fold) to vertebral fractures in both women and men.
There is particularly limited evidence about other NHNV fracture sites. Previous studies generally did not find any association between mortality and other NHNV fractures but were limited by small numbers, leading to grouping of fractures and inability to adjust for comorbidities. Piirtola et al. did not find any association between "other miscellaneous"
fractures (fractures other than hip, vertebra, ribs, proximal humerus and ankle) and mortality, but there were only 47 fractures over 12 years (12). Melton et al. reported "other arm"
fractures (excluding proximal humerus and distal forearm) being associated with increased one-year mortality (13). In the same study, the "other leg group" of fractures (all lower limb fractures other than hip, feet and toes), did not show increased mortality. We found two-to three-fold increased mortality following proximal tibia/fibula, elbow and distal femur fractures in both sexes.
The specific causes of excess mortality following fracture are poorly understood. The duration of increased mortality attributable to fractures is also questionable, so pre-fracture co-morbidities have been hypothesised to contribute significantly to excess mortality with the fracture being a signal of underlying frailty. Several studies have examined the role of comorbidities, mainly following hip fracture (30) (31) (32) . A large Danish hip fracture study did not demonstrate any association between mortality and pre-fracture co-morbidities (31). The major identified causes of mortality were post fracture complications. In the Fracture Intervention Trial, adjustment for co-morbidities also did not affect mortality hazard ratios (28) . Similarly, adjustment for co-morbidities in our study had minimal effect on the fracturespecific hazard ratios although the presence of co-morbidities contributed additively and independently to mortality. Apart from the post fracture mortality, it has been demonstrated that low bone density (33) , sarcopenia (34, 35) , low body weight (21) and weight loss are independent predictors of both fracture and mortality and thus may play a role in any post fracture associated mortality. However, these variables are generally not available in large registry studies.
One criticism of studies in this area is that control groups are often healthier with fewer comorbidities. The current study addressed this using both estimated survival curves and the heuristic approach to calculating population attributable fraction. The estimated survival curves demonstrate visually the difference in mortality risks between an individual with none, one or two co-morbidities following a fracture. In an individual with co-morbidities, fracture and co-morbidity were each independent risk factors for mortality, while the combination of both increased mortality risk. Indeed, a woman with a humeral fracture and one co-morbidity had a similarly reduced 5 year survival to that of a woman with a hip fracture and no comorbidities. Moreover, a fracture with either no or one co-morbidity, accounted for 19% of the deaths in women and 11% in men, which was similar to that for any other individual cocomorbidity including both cancer and cardiovascular disease. Both approaches support fracture as an independent risk factor for mortality and the latter analysis demonstrates the significant contribution of fracture to overall population mortality.
The strengths of the current study include the large sample size of women and men giving statistical power to study individual fracture sites. Unlike previous studies, this dataset captures both community and inpatient data, allowing adjustment for lifestyle factors and medical co-morbidities. Furthermore, the study is the first to estimate population attributable fraction for each level of exposure and delineate the independent and additive effects of comorbidity to fracture-associated mortality.
The limitations of the study include potential underestimation of mortality risk associated with fracture, as 45 and Up Study cohort mortality rates were significantly lower than the general NSW population. However, as increased mortality risk was still observed in this healthy group with fracture, it is likely that this risk would still be evident, and possibly higher, in the general population with a greater number of co-morbidities. Fractures were identified from administrative hospital data so it is possible that not all high trauma fractures were excluded or that only more severe distal fractures were included, potentially overestimating mortality risk in this group. Moreover, the specifics of the fracture event itself was not able to be determined given the nature of the study. While validity of deaths and fracture data is high, validity of self-reported co-morbidities has not been well studied.
However, administrative datasets are likely to under report co-morbid conditions compared with self-report (36). Medication use was not available in the current study so any effect of medication on survival could not be evaluated.
Conclusion
In this large cohort of healthy community-dwelling people, a wide range of non-hip nonvertebral fractures were associated with increased mortality after multivariable adjustment.
Importantly these NHNV fractures accounted for approximately 75% of fractures in this study. Compared to the non-fracture group, women and men with any fracture had a 19% and 25% higher mortality rate, respectively. The population attributable fraction of mortality for any fracture was 9.2% in women and 5.3% in men, similar in magnitude to other well described causes of mortality including cardiovascular disease, diabetes and cancer.
Moreover, using estimated survival curves, this study demonstrated for the first time that individuals with co-morbidities had worse survival after a fracture than those who fractured but were co-morbidity free. This study highlights the potential benefit of early intervention after fracture to reduce risk of further fractures and possibly decrease mortality. 
